LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will present at the following two investor conferences in May:
Conference: Deutsche Bank 43rd Annual Healthcare Conference
Location: Boston, MA
Date: Tuesday, May 8, 2018
Presentation: 3:30 p.m. ET
Speakers: Jim Clemmer, President and Chief Executive Officer, and Michael C. Greiner, Executive Vice President and Chief Financial Officer
Conference: UBS Global Healthcare Conference
Location: New York, NY
Date: Monday, May 21, 2018
Presentation: 9:00 a.m. ET
Speaker: Jim Clemmer, President and Chief Executive Officer
A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following each event.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories drainage products, thrombolytic products and venous products. For more information, visit www.angiodynamics.com.